Familial hyperinsulinism
MONDO:0017182An instance of hyperinsulinism (disease) that is caused by an inherited modification of the individual's genome.
Also known as: hyperinsulinemic hypoglycemia, FHI, HHI, congenital hyperinsulinism, familial hyperinsulinemic hypoglycemia, hereditary hyperinsulinism (disease), hyperinsulinemia of infancy, neonatal hyperinsulinism
11 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New weekly shot shows promise for rare low blood sugar disorder
Disease control OngoingThis study tests a new medicine called HM15136 for people aged 2 and older with congenital hyperinsulinism (CHI) who still have low blood sugar despite standard treatments. The medicine is given as a weekly shot for 8 weeks. The goal is to see if it is safe and helps control bloo…
Phase: PHASE2 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Promising new treatment for rare sugar disorder moves to final testing phase
Disease control OngoingThis study tests an investigational drug called RZ358 for people with congenital hyperinsulinism, a rare condition causing dangerously low blood sugar. The trial involves 56 participants aged 3 months to 45 years who still have low blood sugar despite standard treatments. Over 24…
Phase: PHASE3 • Sponsor: Rezolute • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Newborn screening study aims to catch rare diseases at birth
Diagnosis OngoingThis study offers voluntary screening for newborns in North Carolina to detect a wide range of rare health conditions early. Using a small blood sample already collected at birth, the program tests for dozens of disorders, including spinal muscular atrophy, cystic fibrosis, and m…
Sponsor: RTI International • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC